Drug search by name

Emtricitabine, lopinavir, ritonavir, and tenofovir and Heart block

Result of checking the interaction of drug Emtricitabine, lopinavir, ritonavir, and tenofovir and disease Heart block for safety when used together.

Check result:

Emtricitabine, lopinavir, ritonavir, and tenofovir <> Heart block

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Ritonavir may prolong the PR interval in some patients. Post marketing cases of second or third degree atrioventricular block have been reported. Ritonavir should be administered cautiously in patients with underlying structural heart disease, preexisting conduction abnormalities, ischemic heart disease, and cardiomyopathies as these patients might be at increased risk for developing cardiac conduction abnormalities.

Emtricitabine, lopinavir, ritonavir, and tenofovir

Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir

Brand Name: AccessPak for HIV PEP Expanded with Kaletra

Synonyms: n.a.

What is Emtricitabine, lopinavir, ritonavir, and tenofovir?